Matson (NYSE: MATX) CEO disposes of 10,000 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Matson, Inc.’s Chairman & CEO Matthew J. Cox sold 10,000 shares of common stock in open-market transactions on June 8, 2026. The sales occurred at prices ranging from about $186.05 to $191.66 per share and were executed under a Rule 10b5-1 trading plan adopted on March 9, 2026. Following these pre-planned sales, he continues to hold a substantial direct ownership stake in Matson, according to the filing.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 10,000 shares ($1,900,807)
Net Sell
5 txns
Insider
COX MATTHEW J
Role
Chairman & CEO
Sold
10,000 shs ($1.90M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 147 | $186.127 | $27K |
| Sale | Common Stock | 935 | $189.3531 | $177K |
| Sale | Common Stock | 1,311 | $188.4448 | $247K |
| Sale | Common Stock | 1,456 | $191.0961 | $278K |
| Sale | Common Stock | 6,151 | $190.3941 | $1.17M |
Holdings After Transaction:
Common Stock — 269,149 shares (Direct, null)
Footnotes (1)
- The sale of shares reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2026. This transaction was executed in multiple trades at prices ranging from $186.05 to $186.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $188.80 to $189.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $187.80 to $188.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $190.86 to $191.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $189.84 to $190.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares sold: 10,000 shares
Sale price tranche: $190.3941 per share
Lowest disclosed trade range: $186.05–$186.21 per share
+3 more
6 metrics
Shares sold
10,000 shares
Total Matson common stock sold on June 8, 2026
Sale price tranche
$190.3941 per share
Weighted average sale price for one transaction group on June 8, 2026
Lowest disclosed trade range
$186.05–$186.21 per share
Price range for one set of trades referenced in a footnote
Highest disclosed trade range
$190.86–$191.66 per share
Price range for another trade set referenced in a footnote
Plan adoption date
March 9, 2026
Date the Rule 10b5-1 trading plan was adopted
Transactions reported
5 sale entries
Non-derivative open-market sale transactions in this Form 4
Key Terms
Rule 10b5-1 trading plan, open-market sale, weighted average sale price, non-derivative, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sale of shares ... were effected pursuant to a Rule 10b5-1 trading plan adopted..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open-market sale financial
"transaction_action: "open-market sale" for each non-derivative common stock transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
weighted average sale price financial
"The price reported above reflects the weighted average sale price."
non-derivative financial
"transaction_type: "non-derivative" for each common stock sale entry"
Form 4 regulatory
"The sale of shares reported on this Form 4 were effected pursuant to a Rule 10b5-1..."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What did Matson (MATX) disclose about Matthew J. Cox’s latest stock transactions?
Matson reported that Chairman & CEO Matthew J. Cox sold 10,000 shares of common stock in open-market transactions on June 8, 2026. These trades were executed under a pre-arranged Rule 10b5-1 trading plan, indicating they were scheduled in advance.
Were Matthew J. Cox’s Matson (MATX) stock sales part of a 10b5-1 plan?
Yes. The filing states the sales were made under a Rule 10b5-1 trading plan adopted by Matthew J. Cox on March 9, 2026. Such plans allow insiders to pre-schedule trades, reducing the significance of trade timing as a signal of insider sentiment.
What type of transactions did the Matson (MATX) CEO execute in this Form 4?
All reported transactions were open-market sales of common stock, coded as “S” on the Form 4. The sales were non-derivative, meaning they involved actual shares rather than options or other derivatives, and were executed directly in the market or similar venues.
How were the Matson (MATX) CEO’s sale prices reported in the Form 4?
Each transaction line shows a weighted average sale price, with footnotes explaining that trades were executed in multiple lots within stated price ranges. The CEO has undertaken to provide exact share counts and prices for each lot upon reasonable request.